Iron status in diffuse telogen hair loss among women

Acta Dermatovenerologica Croatica

Volumn 17, Issue 4, 2009, Pages 279-284

  Moeinvaziri, Mojdeh ^a   Mansoori, Parvin ^a   Holakooee, Koorosh ^b   Naraghi, Zahra Safaee ^a   Abbasi, Ali ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anemia; Ferritin; Hair loss; Iron deficiency; Telogen

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; THYROTROPIN; THYROXINE; TRANSFERRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE TELOGEN HAIR LOSS; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; HAIR LOSS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; LEUKOCYTE COUNT; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; ADULT; ALOPECIA; ANEMIA, IRON-DEFICIENCY; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FERRITINS; HUMANS; PREVALENCE; YOUNG ADULT;

EID: 75149152310     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Van Neste DJ, Rushton DH. Hair problems in women. Clin Dermatol 1997;15:113-25.
2. Eckert J, Church RE, Ebling FJ, Munro DS. Hair loss in women. Br J Dermatol 1967;79:543-8.
3. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol 2002;27:389-95.
4. Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol 2002;27:396-404.
5. Headington J. Telogen effluvium: new concepts and review. Arch Dermatol 1993;129:356-63.
6. Kligman A. Pathological dynamics of reversible hair loss in humans. I. Telogen effluvium. Arch Dermatol 1961;83:175-98.
7. Hard S. Non-anemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta DermVenereol 1963;43:562-9.
8. Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 1990;123:187-97.
9. White MI, Currie J, Williams MP. A study of the tissue iron status of patients with alopecia areata. Br J Dermatol 1994;130:261-3.
10. Boffa MJ, Wood P, Griffiths CE. Iron status of patients with alopecia areata. Br J Dermatol 1995;132:662-4.
11. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003;121:985-8.
12. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 2002;147:982-4.
13. Aydingoz IE, Ferhanoglu B, Guney O. Does tissue iron status have a role in female alopecia? J Eur Acad Derm Venereol 1999;13:65-7.
14. Beutler E, Felitti V, Ho NJ, Gelbart T. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferring saturation in patients with iron storage disease. Acta Haematol 2002;107:145-9.
15. rd edn. New York: Churchill-Livingstone; 2000. pp. 397-428.
16. Trost LB, Bergfeld WF, MD, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006;54:824-44.
17. Schrier SL. Causes and diagnosis of anemia due to iron deficiency. Available from: www. UpToDate.com. Accessed April 18, 2005; last updated November 6, 2003.
18. Centers for Disease Control (CDC). Recommendations to prevent and control iron defi-ciency in the United States. Morb Mortal Wkly Rep 1998;47:1-36.
19. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992;7:145-53.
20. Schrier SL, Bacon BR. Pathophysiology and diagnosis of iron overload symptoms. 2004. Available from: www.UpToDate. com. Accessed April 23, 2004; last updated January 9, 2004.
21. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
22. rd edn. Oxford: Oxford University Press; 1997. p. 129.
23. Sinclair R. Diffuse hair loss. Int J Dermatol 1999;38(Suppl 1):8-18.
24. Rushton DH, Ramsey ID. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen dependent alopecia in women. Clin Endocrinol 1992;36:421-7.
25. Hallberg L. Iron absorption and iron deficiency. Hum Nutr Clin Nutr 1982;36:250-78.
26. Larsson LG, Ivhed I, Gidlund M, Pettersson U, Vennstrom B, Nilsson K. Phorbol esterinduced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a V-Myc oncogene. Proc Natl Acad Sci U S A 1988;85:2638-42.
27. Liau G, Chan LM, Feng P. Increased ferritin gene expression is both promoted by cAMP and a marker of growth arrest in rabbit vascular smooth muscle cells. J Biol Chem 1991;266:1819-26.
28. Elledge SJ, Zhou Z, Allen JB. Ribonucleotide reductase: regulation, regulation, regulation. Trends Biochem Sci 1992;17:119-23.